Skip to content

ABT

Abbott Laboratories

Income statement

Income statement
Line, in USDLast 12 months2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue48.2B44.3B42.0B40.1B43.7B43.1B34.6B31.9B30.6B27.4B20.9B20.4B20.2B19.7B19.1B21.4B35.2B30.8B29.5B25.9B
Cost of revenue
20.8B19.3B18.7B18.0B19.1B18.5B15.0B13.2B12.7B12.4B9.1B8.7B9.2B9.2B8.9B10.0B14.7B13.2B12.6B11.4B
Gross profit27.5B25.0B23.2B22.1B24.5B24.5B19.6B18.7B17.9B15.0B11.8B11.7B11.0B10.5B10.2B11.4B20.5B17.6B16.9B14.5B
3.31B2.94B2.84B2.74B2.89B2.74B2.42B2.44B2.30B2.26B1.45B1.41B1.35B1.37B1.46B1.51B3.72B2.74B2.69B2.51B
15.2B12.3B11.7B10.9B11.2B11.3B9.7B9.8B9.7B9.2B6.7B6.8B6.5B6.4B6.7B7.4B10.4B8.4B8.4B7.4B
Other operating expenses
2.34B1.68B1.88B1.97B2.01B2.05B2.13B1.94B2.18B1.98B0.55B0.60B0.56B0.59B0.60B0.88B0.31B0.17B97M—
Operating income6.65B8.05B6.83B6.48B8.36B8.43B5.36B4.53B3.65B1.56B3.03B2.87B2.60B2.13B1.36B1.63B6.09B6.24B5.69B4.58B
Non-operating income
−85M0.41B0.19B0.19B−56M−0.21B−0.39B−0.46B−0.78B0.67B−1.61B0.32B−81M−92M−1.58B−0.39B−0.37B0.96B——
Pretax income6.56B8.47B7.01B6.66B8.31B8.21B4.97B4.08B2.87B2.23B1.41B3.18B2.52B2.04B−0.22B1.24B5.71B7.19B——
Taxes
1.86B1.94B−6.39B0.94B1.37B1.14B0.47B0.39B0.51B1.75B13M−1.24B0.23B−0.54B−6.18B−3.49B1.09B1.45B——
Net income4.7B6.5B13.4B5.7B6.9B7.1B4.5B3.7B2.4B477M1.4B4.4B2.3B2.6B6.0B4.7B4.6B5.7B4.9B3.6B
Diluted EPS2.703.727.643.263.913.942.502.061.330.270.942.921.491.623.723.012.963.693.122.31
Diluted shares—1.75B1.75B1.75B1.76B1.79B1.79B1.78B1.77B1.75B1.48B1.51B1.53B1.57B1.59B1.57B1.56B1.56B1.56B1.56B
Revenue growth—+5.7%+4.6%−8.1%+1.3%+24.5%+8.5%+4.3%+11.6%+31.3%+2.2%+0.8%+3.0%+3.2%−11.0%−39.1%+14.3%+4.2%+13.9%—
Gross margin56.9%56.4%55.4%55.2%56.1%57.0%56.6%58.5%58.4%54.7%56.4%57.1%54.5%53.2%53.3%53.2%58.3%57.1%57.3%55.9%
Operating margin13.8%18.2%16.3%16.2%19.2%19.6%15.5%14.2%11.9%5.7%14.5%14.1%12.8%10.9%7.1%7.6%17.3%20.3%19.3%17.7%
Net margin9.7%14.7%31.9%14.3%15.9%16.4%13.0%11.6%7.7%1.7%6.7%21.7%11.3%13.1%31.3%22.1%13.2%18.7%16.5%13.9%